Bordetella pertussis Isolates with a Heterogeneous Phenotype for Erythromycin Resistance

Erythromycin is currently being used for both prophylaxis and treatment of pertussis infections. Erythromycin resistance was first recognized in Bordetella pertussis in Arizona in 1994, and since then, three additional resistant isolates have been identified in the United States. To better assess th...

Celý popis

Podrobná bibliografie

Vydáno v:	J Clin Microbiol
Hlavní autoři:	Wilson, K. E., Cassiday, P. K., Popovic, T., Sanden, G. N.
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 2002
Témata:	Bacteriology
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC120648/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12149356/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.40.8.2942-2944.2002
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!